Two Sigma Advisers’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-336,800
Closed -$9.16M 2864
2021
Q3
$9.16M Buy
336,800
+132,300
+65% +$3.27M 0.02% 544
2021
Q2
$3.5M Sell
204,500
-33,200
-14% -$621K 0.01% 1032
2021
Q1
$4.96M Sell
237,700
-63,000
-21% -$1.45M 0.01% 854
2020
Q4
$6.89M Buy
300,700
+13,500
+5% +$257K 0.02% 706
2020
Q3
$4.68M Sell
287,200
-36,500
-11% -$661K 0.01% 790
2020
Q2
$4.38M Buy
323,700
+71,400
+28% +$831K 0.01% 848
2020
Q1
$2.99M Buy
252,300
+172,800
+217% +$3.83M 0.01% 912
2019
Q4
$1.98M Sell
79,500
-6,600
-8% -$134K ﹤0.01% 1229
2019
Q3
$1.47M Buy
86,100
+63,700
+284% +$1.16M ﹤0.01% 1251
2019
Q2
$510K Sell
22,400
-6,600
-23% -$178K ﹤0.01% 1805
2019
Q1
$932K Hold
29,000
﹤0.01% 1562
2018
Q4
$817K Buy
29,000
+900
+3% +$26.4K ﹤0.01% 1576
2018
Q3
$808K Sell
28,100
-3,000
-10% -$90.1K ﹤0.01% 1594
2018
Q2
$1.17M Buy
31,100
+19,100
+159% +$750K ﹤0.01% 1546
2018
Q1
$472K Sell
12,000
-24,100
-67% -$880K ﹤0.01% 1838
2017
Q4
$1.17M Buy
36,100
+24,900
+222% +$747K ﹤0.01% 1464
2017
Q3
$349K Buy
+11,200
New +$331K ﹤0.01% 1870
2015
Q3
Sell
-30,700
Closed -$879K 2048
2015
Q2
$879K Buy
+30,700
New +$805K 0.01% 1181

Other funds holding XENT

Two Sigma Advisers's XENT Position: Q4 2021 in Review

Two Sigma Advisers sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 336,800 shares — an estimated $9.16M sold.

Two Sigma Advisers first reported a position in XENT in Q2 2015 and held it in 18 quarters. The position peaked at $9.16M in Q3 2021. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Two Sigma Advisers reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 336,800 Intersect ENT, Inc shares in Q4 2021, an estimated $9.16M.
  • Two Sigma Advisers first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 18 quarters.
  • Two Sigma Advisers's Intersect ENT, Inc position peaked at $9.16M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.